Monday, December 6, 2010

Mouse embryonic stem cells with fluorescent markerImage via Wikipedia
Stem Cell Treatment Holds Promise For MS Patients
A research team at the Cambridge and Edinburgh University has shown that activating stem cells in the brain, specifically the oligodendrocyte precursor cells or OPCs, could reverse the damage caused to the myelin sheath in people affected by the auto immune disease, multiple sclerosis (MS). OPCs are stem cell types that read more

Bookmark and Share
Enhanced by Zemanta